Your browser doesn't support javascript.
loading
CA19-9 decrease and survival according to platelet level in patients with advanced pancreatic cancer.
Chen, Y; Wang, Y R; Deng, G C; Dai, G H.
Afiliação
  • Chen Y; Department of Medical Oncology, Chinese People's Liberation Army (PLA) General Hospital and Chinese PLA Medical School, Beijing, 100853, China.
  • Wang YR; Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Haidian District, Beijing, 100142, China.
  • Deng GC; Department of Medical Oncology, Chinese People's Liberation Army (PLA) General Hospital and Chinese PLA Medical School, Beijing, 100853, China.
  • Dai GH; Department of Medical Oncology, Chinese People's Liberation Army (PLA) General Hospital and Chinese PLA Medical School, Beijing, 100853, China.
BMC Cancer ; 19(1): 860, 2019 Aug 30.
Article em En | MEDLINE | ID: mdl-31470818
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Regulação para Baixo / Antígeno CA-19-9 / Tratamento Farmacológico Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Regulação para Baixo / Antígeno CA-19-9 / Tratamento Farmacológico Idioma: En Ano de publicação: 2019 Tipo de documento: Article